Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | Original Paper

Relationship between basal metabolic rate and cortisol secretion throughout pregnancy

Authors: Svetozar S. Damjanovic, Rada V. Stojic, Nebojsa M. Lalic, Aleksandra Z. Jotic, Djuro P. Macut, Sanja I. Ognjanovic, Milan S. Petakov, Bojana M. Popovic

Published in: Endocrine | Issue 2/2009

Login to get access

Abstract

The role of cortisol in mediating basal metabolic rate (BMR) changes that accompany the adjustment of maternal body weight (BW) and body composition during pregnancy is unknown. We tested whether increase in BMR during pregnancy is explained by variations in cortisol secretion. Longitudinal changes in BW, fat mass (FM), fat-free mass (FFM), BMR, hormonal, and metabolic parameters in 31 parous Caucasian women at gestational weeks 12, 26, and 36 were examined. Individual differences (Δ) between the last and the first measurement occasions for each variable were calculated. By gestational week 36, BW and BMR increased while both FFM/FM and BMR/BW ratio decreased (P < 0.001 for all) suggesting higher proportion of FM accretion. Cortisol, leptin, and insulin-like growth factor-1 (IGF-1) concentration rose, whereas non-placental growth hormone (GH) and thyroid hormones declined (P < 0.001 for all). Insulin resistance changed; basal glucose (P < 0.001) and ghrelin (P < 0.014) declined, whereas insulin (P < 0.001), homeostatic model index (HOMA-IR) (P = 0.041), and free fatty acid (FFA) concentration (P = 0.007) increased. The elevation in BMR showed inverse correlations with ΔBW (r = 0.37, P = 0.047) and Δcortisol (r = −0.53, P = 0.004). Significant portion (51.6%) of the variation in BMR change was explained by increases of cortisol (27.1%), FFA (13.4%), and free triiodothyronine (11.1%). In conclusion, the changes in maternal cortisol concentration are in relationship with changes in BMR and BW, further suggesting that increased cortisol secretion during pregnancy could be linked with the maintenance of maternal BW and body composition.
Literature
1.
go back to reference M. Lof, H. Olausson, K. Bostrom, B. Janerot-Sjöberg, A. Sohlstrom, E. Forsum, Am. J. Clin. Nutr. 81, 678–685 (2005)PubMed M. Lof, H. Olausson, K. Bostrom, B. Janerot-Sjöberg, A. Sohlstrom, E. Forsum, Am. J. Clin. Nutr. 81, 678–685 (2005)PubMed
2.
go back to reference A.M. Prentice, C.J. Spaaij, G.R. Goldberg, S.D. Poppitt, J.M. van Raaij, M. Totton, D. Swann, A.E. Black, Eur. J. Clin. Nutr. 50(Suppl 1), S82–S111 (1996)PubMed A.M. Prentice, C.J. Spaaij, G.R. Goldberg, S.D. Poppitt, J.M. van Raaij, M. Totton, D. Swann, A.E. Black, Eur. J. Clin. Nutr. 50(Suppl 1), S82–S111 (1996)PubMed
4.
go back to reference P.M. Catalano, S.E. Nizielski, J. Shao, L. Preston, L. Qiao, J.E. Friedman, Am. J. Physiol. Endocrinol. Metab. 282, E522–E533 (2001) P.M. Catalano, S.E. Nizielski, J. Shao, L. Preston, L. Qiao, J.E. Friedman, Am. J. Physiol. Endocrinol. Metab. 282, E522–E533 (2001)
5.
go back to reference P.M. Catalano, N.M. Roman-Drago, S.B. Amini, E.A.H. Sims, Am. J. Obstet. Gynecol. 179, 156–165 (1998)CrossRefPubMed P.M. Catalano, N.M. Roman-Drago, S.B. Amini, E.A.H. Sims, Am. J. Obstet. Gynecol. 179, 156–165 (1998)CrossRefPubMed
7.
go back to reference A.M. Johnstone, S.D. Murison, J.S. Duncan, K.A. Rance, J.R. Speakman, Am. J. Clin. Nutr. 82, 941–948 (2005)PubMed A.M. Johnstone, S.D. Murison, J.S. Duncan, K.A. Rance, J.R. Speakman, Am. J. Clin. Nutr. 82, 941–948 (2005)PubMed
8.
go back to reference M. Bolanowski, B.E. Nilsson, Med. Sci. Monit. 7, 1029–1033 (2001)PubMed M. Bolanowski, B.E. Nilsson, Med. Sci. Monit. 7, 1029–1033 (2001)PubMed
9.
go back to reference G. Larciprete, H. Valensise, B. Vasapollo, F. Altomare, R. Sorge, B. Casalino, A. De Lorenzo, D. Arduini, Acta Diabetol. 40((Suppl 1)), S225–S232 (2003)CrossRefPubMed G. Larciprete, H. Valensise, B. Vasapollo, F. Altomare, R. Sorge, B. Casalino, A. De Lorenzo, D. Arduini, Acta Diabetol. 40((Suppl 1)), S225–S232 (2003)CrossRefPubMed
10.
go back to reference M. Rebuffe-Scrive, L. Enk, N. Crona, P. Lönnroth, L. Abrahamsson, U. Smith, P. Björntorp, J. Clin. Invest. 75, 1973–1976 (1985)CrossRefPubMed M. Rebuffe-Scrive, L. Enk, N. Crona, P. Lönnroth, L. Abrahamsson, U. Smith, P. Björntorp, J. Clin. Invest. 75, 1973–1976 (1985)CrossRefPubMed
11.
go back to reference A. Astrup, P.C. Gøtzsche, K. de Werken, C. Ranneries, S. Toubro, A. Raben, B. Buemann, Am. J. Clin. Nutr. 69, 1117–1122 (1999)PubMed A. Astrup, P.C. Gøtzsche, K. de Werken, C. Ranneries, S. Toubro, A. Raben, B. Buemann, Am. J. Clin. Nutr. 69, 1117–1122 (1999)PubMed
12.
go back to reference C. Bogardus, S. Lillioja, E. Ravussin, W. Abbott, J.K. Zawadzki, A. Young, W.C. Knowler, R. Jacobowitz, P.P. Moll, N. Engl. J. Med. 315, 96–100 (1986)CrossRefPubMed C. Bogardus, S. Lillioja, E. Ravussin, W. Abbott, J.K. Zawadzki, A. Young, W.C. Knowler, R. Jacobowitz, P.P. Moll, N. Engl. J. Med. 315, 96–100 (1986)CrossRefPubMed
13.
go back to reference C. Bouchard, A. Tremblay, A. Nadeau, J.P. Després, G. Thériault, M.R. Boulay, G. Lortie, C. Leblanc, G. Fournier, Metabolism 38, 364–370 (1989)CrossRefPubMed C. Bouchard, A. Tremblay, A. Nadeau, J.P. Després, G. Thériault, M.R. Boulay, G. Lortie, C. Leblanc, G. Fournier, Metabolism 38, 364–370 (1989)CrossRefPubMed
14.
go back to reference E. Ravussin, C. Bogardus, Am. J. Clin. Nutr. 49(Suppl 5), S968–S975 (1989) E. Ravussin, C. Bogardus, Am. J. Clin. Nutr. 49(Suppl 5), S968–S975 (1989)
15.
go back to reference M. Elia, in Energy metabolism: tissue determinants and cellular corollaries: energy expenditure in the whole body, ed. by J.M. Kinney, H.N. Tucker (Raven, New York, 1992) M. Elia, in Energy metabolism: tissue determinants and cellular corollaries: energy expenditure in the whole body, ed. by J.M. Kinney, H.N. Tucker (Raven, New York, 1992)
16.
17.
go back to reference T.M. Mizuno, H. Makimura, J. Silverstein, J.L. Roberts, T. Lopingco, C.V. Mobbs, Endocrinology 140, 4551–4557 (1999)CrossRefPubMed T.M. Mizuno, H. Makimura, J. Silverstein, J.L. Roberts, T. Lopingco, C.V. Mobbs, Endocrinology 140, 4551–4557 (1999)CrossRefPubMed
18.
20.
go back to reference K.D. Niswender, D.B. Baskin, M.W. Schwartz, Trends Endocrinol. Metab. 15, 362–369 (2004)PubMed K.D. Niswender, D.B. Baskin, M.W. Schwartz, Trends Endocrinol. Metab. 15, 362–369 (2004)PubMed
21.
go back to reference J. Fuglsang, C. Skjaerbaek, U. Espelund, J. Frystyk, S. Fisker, A. Flyvbjerg, P. Ovesen, Clin. Endocrinol. 62, 554–559 (2005)CrossRef J. Fuglsang, C. Skjaerbaek, U. Espelund, J. Frystyk, S. Fisker, A. Flyvbjerg, P. Ovesen, Clin. Endocrinol. 62, 554–559 (2005)CrossRef
22.
go back to reference M. Riedl, C. Maier, A. Handisurya, A. Luger, A. Kautzky-Willer, J. Intern. Med. 262, 458–465 (2007)CrossRefPubMed M. Riedl, C. Maier, A. Handisurya, A. Luger, A. Kautzky-Willer, J. Intern. Med. 262, 458–465 (2007)CrossRefPubMed
23.
go back to reference M.K. Bauer, J.E. Harding, N.S. Bassett, B.H. Breier, M.H. Oliver, B.H. Gallaher, P.C. Evans, S.M. Woodall, P.D. Gluckman, Mol. Cell. Endocrinol. 140, 115–120 (1998)CrossRefPubMed M.K. Bauer, J.E. Harding, N.S. Bassett, B.H. Breier, M.H. Oliver, B.H. Gallaher, P.C. Evans, S.M. Woodall, P.D. Gluckman, Mol. Cell. Endocrinol. 140, 115–120 (1998)CrossRefPubMed
24.
go back to reference M. Hernandez-Valencia, A. Zarate, R. Ochoa, M.E. Fonseca, D. Amato, O.M. de Jesus, Diabetes Obes. Metab. 3, 457–462 (2001)CrossRefPubMed M. Hernandez-Valencia, A. Zarate, R. Ochoa, M.E. Fonseca, D. Amato, O.M. de Jesus, Diabetes Obes. Metab. 3, 457–462 (2001)CrossRefPubMed
28.
go back to reference M. Rosenbaum, R. Goldsmith, D. Bloomfield, A. Magnano, L. Weimer, S. Heymsfield, D. Gallagher, L. Mayer, E. Murphy, R.L. Leibel, J. Clin. Invest. 115, 3579–3586 (2005)CrossRefPubMed M. Rosenbaum, R. Goldsmith, D. Bloomfield, A. Magnano, L. Weimer, S. Heymsfield, D. Gallagher, L. Mayer, E. Murphy, R.L. Leibel, J. Clin. Invest. 115, 3579–3586 (2005)CrossRefPubMed
29.
go back to reference M.A. Borg, R.S. Sherwin, W.P. Borg, W.V. Tamborlane, G.I. Shulman, J. Clin. Invest. 99, 361–365 (1997)CrossRefPubMed M.A. Borg, R.S. Sherwin, W.P. Borg, W.V. Tamborlane, G.I. Shulman, J. Clin. Invest. 99, 361–365 (1997)CrossRefPubMed
30.
go back to reference B.E. Levin, A.A. Dunn-Meynell, V.H. Routh, Am. J. Physiol. Regul. Integr. Comp. Physiol. 276, R1223–R1231 (1999) B.E. Levin, A.A. Dunn-Meynell, V.H. Routh, Am. J. Physiol. Regul. Integr. Comp. Physiol. 276, R1223–R1231 (1999)
31.
go back to reference C.V. Mobbs, L.M. Kow, X.J. Yang, Am. J. Physiol. Endocrinol. Metab. 281, E649–E654 (2001)PubMed C.V. Mobbs, L.M. Kow, X.J. Yang, Am. J. Physiol. Endocrinol. Metab. 281, E649–E654 (2001)PubMed
32.
34.
go back to reference B. Allolio, J. Hoffmann, E.A. Linton, W. Winkelmann, M. Kusche, H.M. Schulte, Clin. Endocrinol. 33, 279–289 (1990)CrossRef B. Allolio, J. Hoffmann, E.A. Linton, W. Winkelmann, M. Kusche, H.M. Schulte, Clin. Endocrinol. 33, 279–289 (1990)CrossRef
36.
go back to reference N.A.T.M. Huizenga, J.W. Koper, P. de Lange, H.A.P. Pols, R.P. Stolk, D.E. Grobbee, F.H. de Jong, S.W.J. Lamberts, J. Clin. Endocrinol. Metab. 83, 47–54 (1998)CrossRefPubMed N.A.T.M. Huizenga, J.W. Koper, P. de Lange, H.A.P. Pols, R.P. Stolk, D.E. Grobbee, F.H. de Jong, S.W.J. Lamberts, J. Clin. Endocrinol. Metab. 83, 47–54 (1998)CrossRefPubMed
37.
go back to reference M. Bartels, E.J.C. de Geus, C. Kirschbaum, F. Sluyter, D.I. Boomsma, Behav. Genet. 33, 421–433 (2003)CrossRefPubMed M. Bartels, E.J.C. de Geus, C. Kirschbaum, F. Sluyter, D.I. Boomsma, Behav. Genet. 33, 421–433 (2003)CrossRefPubMed
38.
go back to reference A. Peters, U. Schweiger, L. Pellerin, C. Hubold, K.M. Oltmanns, M. Conrad, B. Schultes, J. Born, H.L. Fehm, Neurosci. Biobehav. Rev. 28, 143–180 (2004)CrossRefPubMed A. Peters, U. Schweiger, L. Pellerin, C. Hubold, K.M. Oltmanns, M. Conrad, B. Schultes, J. Born, H.L. Fehm, Neurosci. Biobehav. Rev. 28, 143–180 (2004)CrossRefPubMed
41.
go back to reference Y. Minokoshi, K. Young-Bum, O.D. Peroni, L.G.D. Fryer, C. Muller, D. Carling, B.B. Kahn, Nature 415, 339–343 (2002)CrossRefPubMed Y. Minokoshi, K. Young-Bum, O.D. Peroni, L.G.D. Fryer, C. Muller, D. Carling, B.B. Kahn, Nature 415, 339–343 (2002)CrossRefPubMed
42.
go back to reference N.C. Okereke, L. Huston-Presley, S.B. Amini, S. Kalhan, P.M. Catalano, Am. J. Physiol. Endocrinol. Metab. 287, E472–E479 (2004)CrossRefPubMed N.C. Okereke, L. Huston-Presley, S.B. Amini, S. Kalhan, P.M. Catalano, Am. J. Physiol. Endocrinol. Metab. 287, E472–E479 (2004)CrossRefPubMed
43.
go back to reference C. Verdich, S. Toubro, B. Buemann, J.J. Holst, J. Bulow, L. Simonsen, S.B. Sondergaards, N.J. Christensen, A. Astrup, Obes. Res. 9, 452–461 (2001)CrossRefPubMed C. Verdich, S. Toubro, B. Buemann, J.J. Holst, J. Bulow, L. Simonsen, S.B. Sondergaards, N.J. Christensen, A. Astrup, Obes. Res. 9, 452–461 (2001)CrossRefPubMed
44.
go back to reference V. White, E. González, E. Capobianco, C. Pustovrh, N. Martínez, R. Higa, M. Baier, A. Jawerbaum, Reprod. Fertil. Dev. 18, 425–432 (2006)CrossRefPubMed V. White, E. González, E. Capobianco, C. Pustovrh, N. Martínez, R. Higa, M. Baier, A. Jawerbaum, Reprod. Fertil. Dev. 18, 425–432 (2006)CrossRefPubMed
45.
go back to reference C. Nunez, D. Gallagher, M. Visser, F.X. Pi-Sunyer, Z.M. Wang, S.B. Heymsfield, Med. Sci. Sports Exerc. 29, 524–531 (1997)PubMed C. Nunez, D. Gallagher, M. Visser, F.X. Pi-Sunyer, Z.M. Wang, S.B. Heymsfield, Med. Sci. Sports Exerc. 29, 524–531 (1997)PubMed
47.
go back to reference J. Siedel, E.O. Hagele, J. Ziegenhorn, A.W. Wahlefeld, Clin. Chem. 29, 1075–1080 (1983)PubMed J. Siedel, E.O. Hagele, J. Ziegenhorn, A.W. Wahlefeld, Clin. Chem. 29, 1075–1080 (1983)PubMed
49.
go back to reference A.N. Wahlefeld, in Methods of enzymatic analysis: triglycerides determination after enzymatic hydrolysis, ed. by H.V. Bergmayer (Academic Press, New York, 1974) A.N. Wahlefeld, in Methods of enzymatic analysis: triglycerides determination after enzymatic hydrolysis, ed. by H.V. Bergmayer (Academic Press, New York, 1974)
50.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)CrossRefPubMed
Metadata
Title
Relationship between basal metabolic rate and cortisol secretion throughout pregnancy
Authors
Svetozar S. Damjanovic
Rada V. Stojic
Nebojsa M. Lalic
Aleksandra Z. Jotic
Djuro P. Macut
Sanja I. Ognjanovic
Milan S. Petakov
Bojana M. Popovic
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9137-z

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine